These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22710190)

  • 1. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.
    Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Chen W; Pang KC; Liu XF; Liu T; Zhang JY; Zeng H; Liu KY; Guo G; Tong WD; Shi Y; Tang B; Li N; Yu S; Luo P; Zhang WJ; Lu DS; Yu PW; Zou QM
    Gastroenterology; 2012 Oct; 143(4):951-62.e8. PubMed ID: 22710190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
    Kuang DM; Peng C; Zhao Q; Wu Y; Zhu LY; Wang J; Yin XY; Li L; Zheng L
    J Immunol; 2010 Aug; 185(3):1544-9. PubMed ID: 20581151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer.
    Saito H; Yamada Y; Takaya S; Osaki T; Ikeguchi M
    Surg Today; 2015 Nov; 45(11):1429-35. PubMed ID: 25869448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis.
    Zhao BC; Zhao B; Han JG; Ma HC; Wang ZJ
    Hepatogastroenterology; 2010; 57(104):1382-9. PubMed ID: 21443090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and mechanisms of interleukin-17 in CD(8)(+) T cells of mice with cigarette smoke-induced emphysema].
    Duan MC; Zhong XN; Huang Y; He ZY; Tang HJ
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):776-80. PubMed ID: 22176968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
    Kondo T; Takata H; Matsuki F; Takiguchi M
    J Immunol; 2009 Feb; 182(4):1794-8. PubMed ID: 19201830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17-polarizing conditions.
    Tsai JP; Lee MH; Hsu SC; Chen MY; Liu SJ; Chang JT; Liao CT; Cheng AJ; Chong P; Chu CL; Shen CR; Chen HW
    J Immunol; 2012 Aug; 189(4):1671-9. PubMed ID: 22798680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.
    Ma YY; He XJ; Wang HJ; Xia YJ; Wang SL; Ye ZY; Tao HQ
    Cancer Sci; 2011 Feb; 102(2):336-42. PubMed ID: 21134074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
    Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
    Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.
    Osaki T; Saito H; Yoshikawa T; Matsumoto S; Tatebe S; Tsujitani S; Ikeguchi M
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):382-7. PubMed ID: 17255258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CD8+CD28- T-suppressor cells in gastric cancer patients.
    Shen Y; Qu QX; Zhu YB; Zhang XG
    J Immunoassay Immunochem; 2012; 33(2):149-55. PubMed ID: 22471605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
    Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
    Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1.
    Lu X; Liu J; Li H; Li W; Wang X; Ma J; Tong Q; Wu K; Wang G
    J Surg Oncol; 2011 Nov; 104(6):571-7. PubMed ID: 21695703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
    van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
    Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.